Liraglutide
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Novo Nordisk · Phase 3 · Completed · Enrollment 359
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Liraglutide 3.0 mg | Obesity or overweight | 3.0 mg | 32 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 32 | n/r | n/r |